Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: J Psychosom Res. 2019 Apr 12;121:68–73. doi: 10.1016/j.jpsychores.2019.04.004

Table 3.

Demographic and clinical characteristics of kidney transplant candidates with comorbid cannabis use disorders (based on cannabis dependence vs abuse diagnoses)

Characteristic Dependence (n=40) Abuse (n=21) Total (n=61) p Value
Females 13 (33%) 8 (38%) 21 (34%) 0.78
Age at Initial Evaluation 45 (34, 52) 49 (33, 55) 45 (33, 52) 0.73
White 29 (73) 17 (81%) 46 (75%) 0.55
Married 11 (28%) 9 (43%) 20 (33%) 0.26
Psychiatric Follow-Up 17 (43%) 11 (52%) 28 (46%) 0.59
Sobriety Achieved 33 (83%) 21 (100%) 54 (89%) 0.08
Smokers at Initial Evaluation 16 (41%) 7 (33%) 23 (38%) 0.59
History of Daily Cannabis Use 33 (85%) 2 (10%) 35 (58%) <0.001
History of Alcohol Dependence 23 (59%) 5 (24%) 28 (47%) 0.01
History of Alcohol Abuse 5 (13%) 11 (52%) 16 (27%) 0.002
History of Drug Dependence 15 (40%) 3 (14%) 18 (31%) 0.08
History of Drug Abuse 6 (16%) 2 (10%) 8 (14%) 0.70
Family History of SUD in First-Degree Relative 24 (65 %) 10 (50%) 34 (60%) 0.40
Depressive Disorder 17 (44%) 8 (38 %) 25 (42%) 0.79
Anxiety Disorder 11 (28%) 5 (24%) 16 (27%) 0.77
Listed/Transplanted 13 (33%) 14 (67%) 27 (44%) 0.02
Time from Initial Psych Evaluation to Listing 32 (7, 321) 346 (20, 780) 60 (8, 599) 0.10